Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 7 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors at 3 institutions in 2 countries.
Damiano RocchiUnidad de Química Orgánica y Farmacéutica, Departamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad Complutense, 28040 Madrid, Spain.ORCID 0000-0002-8235-2717
Juan F GonzálezUnidad de Química Orgánica y Farmacéutica, Departamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad Complutense, 28040 Madrid, Spain.ORCID 0000-0002-4568-7200
Olmo Martín-CámaraUnidad de Química Orgánica y Farmacéutica, Departamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad Complutense, 28040 Madrid, Spain.ORCID 0000-0002-3261-8492
Maria Grazia PerroneDipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari Aldo Moro, 70121 Bari, Italy.ORCID 0000-0003-4195-5228
Morena MiciacciaDipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari Aldo Moro, 70121 Bari, Italy.ORCID 0000-0002-0727-6435
Antonio ScilimatiDipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari Aldo Moro, 70121 Bari, Italy.ORCID 0000-0003-2740-6425
Celine Decouty-PérezMolecular Neuroinflammation and Neuronal Plasticity Research Laboratory, Hospital Universitario Santa Cristina, Instituto de Investigación Sanitaria-Hospital Universitario de la Princesa, 28009 Madrid, Spain.
Esther ParadaMolecular Neuroinflammation and Neuronal Plasticity Research Laboratory, Hospital Universitario Santa Cristina, Instituto de Investigación Sanitaria-Hospital Universitario de la Princesa, 28009 Madrid, Spain.
Javier EgeaMolecular Neuroinflammation and Neuronal Plasticity Research Laboratory, Hospital Universitario Santa Cristina, Instituto de Investigación Sanitaria-Hospital Universitario de la Princesa, 28009 Madrid, Spain.ORCID 0000-0003-4704-3019
J Carlos MenéndezUnidad de Química Orgánica y Farmacéutica, Departamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad Complutense, 28040 Madrid, Spain.ORCID 0000-0002-0560-8416
Universidad Complutense de Madrid · ESHospital Universitario Santa Cristina · ESUniversity of Bari Aldo Moro · IT
Funding
Fondo de Investigaciones Sanitarias (FIS) (ISCIII/FEDER) PI19/00082Fondo de Investigaciones Sanitarias (FIS) (ISCIII/FEDER) PI22/00362Fundación Mutua Madrileña AP177352021Ministerio de Ciencia e Innovación PID2021-124983OB-I00
6 · The paper itself
Abstract
Inhibition of cyclooxygenase-2 (COX-2) has been extensively studied as an approach to reduce proinflammatory markers in acute brain diseases, but the anti-neuroinflammatory role of cyclooxygenase-1 (COX-1) inhibition has been rather neglected. We report that
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.